Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of ...

18-04-2011 PR Newswire (press release)Comments (0)


Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program ...

Read more on PR Newswire (press release)

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top